[ad_1] Drug firm Piramal Pharma Ltd on Thursday (March 20) said Piramal Critical Care (PCC) and Ireland-based BrePco Biopharma Ltd (BPCO) have received UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval for Naeoatricon, the first paediatric-strength dopamine hydrochloride infusion for treating hypotension in neonates, infants, and children. Piramal Critical Care has secured commercialisation rights […]
Piramal Pharma’s critical care division launches Chlorpromazine injection in US – CNBC TV18
[ad_1] Piramal Pharma Ltd on Wednesday (January 22) said its division Piramal Critical Care (PCC) has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. The product will be available in two vial formats—25 mg/1 mL and 50 mg/2 mL—marking an expansion of PCC’s generic injectables portfolio. Company Value Change %Change The launch of […]